RGEN Financials
Repligen Corporation - Financial statements & key metrics
Stock Price
$172.36
Market Cap
$7.43B
P/E Ratio
8365.5
EPS
$0.02
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-25.51M
EPS (Diluted)
$-0.46
Balance Sheet Highlights
Total Assets
$2.83B
Total Liabilities
$856.95M
Shareholders Equity
-
Cash & Equivalents
$757.36M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$175.39M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
6.7%
Net Margin
0.3%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is RGEN revenue?
View RGEN's income statement for detailed revenue data.
Is RGEN profitable?
RGEN reported a loss of $25.51M in the most recent quarter. The net profit margin is 0.3%.
What is RGEN market cap?
RGEN has a market capitalization of $7.43B, making it a mid-cap stock.
Does RGEN have debt?
View RGEN's balance sheet for debt information.
What is RGEN cash flow?
Cash flow data is available in the full financial statements.